Senti Biosciences, Inc. (SNTI) vs Theriva Biologics, Inc. (TOVX)

Senti Biosciences, Inc. and Theriva Biologics, Inc. are both Biotechnology companies. Senti Biosciences, Inc. and Theriva Biologics, Inc. are of similar size ($10.6M and $10.0M). Senti Biosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Theriva Biologics, Inc. trades at 0.2×. Theriva Biologics, Inc. has the higher net margin (0.00% vs −3,789.3%) and the lower return on invested capital (−301.7% vs 0.00%). Across the 13 metrics below, Theriva Biologics, Inc. leads on 9 and Senti Biosciences, Inc. on 4.

Valuation

Metric SNTI TOVX Biotechnology median
P/E n/m 0.16 7.88
P/S 7.86 n/m 11.47
P/B n/m 0.83 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 2.94 n/m 10.73
Earnings yield (536.36%) 642.32% (28.84%)
Free cash flow yield (369.11%) (126.58%) (23.03%)

Profitability

Metric SNTI TOVX Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (4,181.12%) 0.00% 0.00%
Net margin (3,789.30%) 0.00% 0.00%
Free cash flow margin (2,900.38%) 0.00% 0.00%
Return on equity (466.46%) (115.11%) (57.72%)
Return on assets (97.52%) (37.14%) (49.22%)
Return on invested capital 0.00% (301.72%) 0.00%

Growth

Metric SNTI TOVX Biotechnology median
Revenue growth (TTM) (70.73%) — 5.64%
EPS growth (last fiscal year) 77.31% 89.07% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric SNTI TOVX Biotechnology median
Debt to equity 0.00 0.13 0.00
Current ratio 0.83 1.13 4.73
Net debt to EBITDA 0.25 0.48 0.96

Dividend

Metric SNTI TOVX Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric SNTI TOVX Biotechnology median
Market cap 9.96m 10.58m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack